Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Companies Reap EU Research Rewards

Millions of euros of EU research money is being directed towards controversial projects which do not benefit the public interest, according to new research from Corporate Europe Observatory published today [1].

The report, which is launched as the European Commission hosts a conference on research in Brussels [2], says that the approval of so-many controversial projects is not surprising, given that many of the companies were also involved in writing the EU’s Strategic Research Agenda, which sets the priorities for new research.

Projects receiving funding under the Seventh Framework Programme (FP7) include research into genetically modified trees and crops, research in coordination with Brazil to foster agrofuel imports from Latin America, and research into the use of agrofuels for aviation.

Corporate Europe Observatory (CEO) has criticised the funding priorities which it says fail to assess the public benefits of the schemes.

Report author Amaranta Herrero from CEO said:

“These projects are being given public money but they will not benefit EU taxpayers, or the public in general. Instead the European Commission gives private companies priviliged access in deciding how public funds are spent. The companies involved must be laughing all the way to the bank.”

Companies including Shell, Syngenta, Novozymes, Bayer, SEKAB, Abengoa, Repsol and SweTree Technologies were involved in writing the EU’s Strategic Research Agenda after they were invited to join the Commission’s European Biofuels Technology Platform (EBFTP) [3]. All have so far received funding under FP7.

The research highlights the threats posed by some of the projects being funded, in particular the risk posed by GE trees. SweTree Technologies wants to modify trees to reduce the lignin content, which gives trees their rigidity. But the report authors say this will make the trees vulnerable and put natural forests at risk if they are exposed to this genetic trait.

Nina Holland, co-author of the report, added:
“Projects to genetically engineer trees for biomass pose a major threat to the survival of our forests, while increased agrofuel production will result in further monoculture expansion in Latin America and elsewhere. These energy projects to develop alternative fuels are as damaging as the fossil fuels they seek to replace.”

Contact:

Amaranta Herrero: + 34 935812503
Nina Holland: + 32 497 389 632 (Thursday: + 31 6 30285042)

Notes:
[1] Agrofuels and the EU research budget: public funding for private interests, Corporate Europe Observatory, 27 May 2009,
http://www.corporateeurope.org/agrofuels/content/2009/05/agrofuels-and-eu-research-budget
[2] 'Sustainable Development; a Challenge for European Research', Brussels, 26-28 May
[3] http://www.corporateeurope.org/agrofuels/content/2009/04/industry-pushes-25-agrofuel-target
Related issues: 
 

Food safety, the environment, and consumer choice are at stake, as biotech industry lobbyists pressure decision makers to deregulate a new generation of genetic engineering techniques ahead of a crucial European Commission decision in February.

The voice of the Dutch Government has been loud and clear in Brussels on the issue of cisgenic plants. The Dutch have waged a sustained campaign to have new GM techniques – and in particular cisgenesis – excluded from EU GMO regulations. Several Dutch ministries, the Dutch Parliament, the Dutch Permanent Representation in Brussels, and Dutch MEPs have energetically pursued this goal.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

Commission refuses to act on the recommendations of the European Ombudsman regarding tobacco industry lobbying.

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

The corporate lobby tour

Stop the Crop

Alternative Trade Mandate